BioSpace News Archive

By using single-cell analysis to measure metabolic activities in rare disseminated tumor cells taken from non-small cell lung cancer patients, Institute for Systems Biology researchers and their collaborators can accurately predict how patients will respond to various cancer therapies, and how treatments will impact a patient’s physiological performance and survival.

Cognate BioServices announced it has secured a financial sponsor to support its short-term and long-term growth as it closed on a round of growth capital from EW Healthcare Partners.

Evofem Biosciences, Inc. announced the last patient has completed her last visit in AMPREVENCE, the Phase 2b clinical trial evaluating the Company’s lead product candidate Amphora®, a Multipurpose Vaginal pH Regulator, for the prevention of acquisition of chlamydia and gonorrhea in women.

Aerie Pharmaceuticals, Inc. announced the appointment of Luis Vargas, M.D., as Medical Director, Medical Affairs, reporting to Welyn Bui, PharmD, Aerie’s Vice President of Medical Affairs.

Eli Lilly and Company announced that the U.S. Food and Drug Administration has approved Taltz® injection 80 mg/mL for the treatment of adults with active ankylosing spondylitis, also known as radiographic axial spondyloarthritis.

We know the facts: Girls are less likely to be encouraged to study science, technology, engineering and math.

Atonarp, a hi-tech molecular diagnostics company, announced that it has raised $33 million in an oversubscribed Series C funding round.

Prancer RTSM Selected for Innovation in Cohort Management for Highly Complex Trials

BELLUS Health Inc. announced the appointment of Dr. Catherine Bonuccelli, MD to the role of Chief Medical Officer.

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announces the immediate appointment of Priya Chaturvedi, Ph.D., as Vice President, Global Clinical Quality Assurance.